• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[1例Ph1阳性慢性粒细胞白血病患者在白消安诱导缓解期间染色体正常造血的表现]

[Appearance of chromosomally normal hemopoiesis during busulfan-induced remission in a case of Ph1 positive chronic myelogenous leukemia].

作者信息

Takahira H, Ideguchi H, Hirata J, Nishimura J, Nawata H, Shimizu S

出版信息

Rinsho Ketsueki. 1989 Feb;30(2):251-5.

PMID:2746880
Abstract

A 33-year-old female was admitted to St. Marianna University hospital in April 1983 for the purpose of examination for leukocytosis. Physical examination revealed a marked splenomegaly. The white cell count was 174 x 10(9)/l. The hemoglobin was 9.0 g/dl and the platelet was 790 x 10(9)/l. Microscopical examination of aspirated specimen of bone marrow revealed hypercellularity with granulocytic hyperplasia. The chromosomal analysis of bone marrow cells showed Philadelphia chromosomes in all metaphases analyzed. The neutrophil alkaline phosphatase activity was reduced. A diagnosis of CML was made. She was treated with busulfan in a dose of 2 mg/day until the white cell count was 14.5 x 10(9)/l. She has been followed without any therapy and clinical remission state has been continued. In April 1985, the chromosomal analysis of bone marrow cells revealed the recovery of normal karyotype hemopoiesis in 57% of metaphases analyzed. These findings of this case suggest that some of Ph1-positive cells may reduce their growth advantage over normal cells without any bone marrow hypoplasia.

摘要

一名33岁女性于1983年4月因白细胞增多症检查入住圣玛丽安娜大学医院。体格检查发现脾脏明显肿大。白细胞计数为174×10⁹/L。血红蛋白为9.0g/dl,血小板为790×10⁹/L。骨髓穿刺标本显微镜检查显示细胞增多伴粒细胞增生。骨髓细胞染色体分析显示所有分析的中期细胞均有费城染色体。中性粒细胞碱性磷酸酶活性降低。诊断为慢性粒细胞白血病。她接受了每日2mg白消安的治疗,直至白细胞计数降至14.5×10⁹/L。此后未进行任何治疗,一直对其进行随访,临床缓解状态持续存在。1985年4月,骨髓细胞染色体分析显示,在分析的中期细胞中,57%恢复了正常核型造血。该病例的这些发现表明,一些Ph1阳性细胞可能在不发生任何骨髓发育不全的情况下,降低其相对于正常细胞的生长优势。

相似文献

1
[Appearance of chromosomally normal hemopoiesis during busulfan-induced remission in a case of Ph1 positive chronic myelogenous leukemia].[1例Ph1阳性慢性粒细胞白血病患者在白消安诱导缓解期间染色体正常造血的表现]
Rinsho Ketsueki. 1989 Feb;30(2):251-5.
2
[One-year remission of chronic myelogenous leukemia (CML) after discontinuation of interferon-alpha].
Rinsho Ketsueki. 1990 Jul;31(7):1013-6.
3
[Disappearance of Philadelphia chromosomes after remission induction in lymphoid crisis of chronic myelogenous leukemia].[慢性粒细胞白血病淋巴危象缓解诱导后费城染色体消失]
Rinsho Ketsueki. 1992 Sep;33(9):1226-30.
4
[Discrepancy in karyotypes between peripheral blood and bone marrow during blastic crisis in chronic myelocytic leukemia].[慢性粒细胞白血病急变期外周血与骨髓核型的差异]
Rinsho Ketsueki. 1989 Jul;30(7):1032-6.
5
[Partial and complete disappearance of Ph1 chromosome in two patients with chronic myelogenous leukemia after conventional chemotherapy].[两名慢性粒细胞白血病患者经传统化疗后费城染色体部分及完全消失]
Rinsho Ketsueki. 1993 Jun;34(6):733-7.
6
Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.在慢性粒细胞白血病患者接受未处理造血细胞自体移植后,使用粒细胞巨噬细胞集落刺激因子(GM-CSF)联合羟基脲作为移植后治疗方法。
Haematologica. 1997 May-Jun;82(3):291-6.
7
[Bone marrow aplasia without blast crisis in a case of CML of 10-year survival].[慢性粒细胞白血病患者骨髓再生障碍且无原始细胞危象,生存10年病例]
Rinsho Ketsueki. 1989 May;30(5):752-6.
8
Durable molecular remission in a patient with chronic myelogenous leukemia and host-derived hematopoiesis after allogeneic bone marrow transplantation.
Bone Marrow Transplant. 1996 Oct;18(4):801-4.
9
[A trial for prolongation of chronic phase of chronic myeloid leukemia--maintenance of leukocyte counts within normal range with busulfan].
Rinsho Ketsueki. 1989 May;30(5):625-30.
10
[A case of chronic myelogenous leukemia complicated with nephrotic syndrome].
Rinsho Ketsueki. 1989 May;30(5):691-6.